Literature DB >> 12653220

PON1 paraoxonase activity is reduced during HDL oxidation and is an indicator of HDL antioxidant capacity.

Leila Jaouad1, Christelle Milochevitch, Abdelouahed Khalil.   

Abstract

The aim of this study was to investigate the effect of HDL oxidation on PON1 paraoxonase activity. Also, we were interested in investigating the mechanism by which PON1 could be inactivated and the correlation between its enzymatic activity and the antioxidant properties of HDL. Three different oxidation systems were used for the HDL oxidation: (1) oxidation induced by THP1 cells, (2) oxidation induced by copper ions at a concentration 10 microM, and (3) oxidation induced by *OH and O2.- oxygen free radicals produced by gamma-radiolysis. HDL oxidation was followed by the measurement of lipid peroxide formation, and PON1 activity was determined by measuring the rate of paraoxon hydrolysis. Our results show that HDL oxidation is accompanied by a reduction in the PON1 paraoxonase activity. The extent of PON1 inactivation depends both on the extent of HDL oxidation and on the oxidation system used. The rates of HDL oxidation and PON1 inactivation were significantly correlated (r = 0.93, p < 0.0054). Our results show that oxidized HDL loses its protective effect toward LDL oxidation. The antioxidant action of HDL towards LDL oxidation and the degradation of PON1 paraoxonase activity were significantly correlated (r = 0.95, p < 0.04).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12653220     DOI: 10.1080/1071576021000036614

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  15 in total

1.  HDL anti-oxidant function associates with LDL level in young adults.

Authors:  Carrie V Breton; Fen Yin; Xinhui Wang; Ed Avol; Frank D Gilliland; Jesus A Araujo
Journal:  Atherosclerosis       Date:  2013-11-15       Impact factor: 5.162

2.  Time-dependent modulation of rat serum paraoxonase 1 activity by fasting.

Authors:  Elena Thomàs-Moyà; Antònia Nadal-Casellas; Magdalena Gianotti; Isabel Lladó; Ana María Proenza
Journal:  Pflugers Arch       Date:  2006-12-05       Impact factor: 3.657

Review 3.  Modifying the anti-inflammatory effects of high-density lipoprotein.

Authors:  Benjamin J Ansell; Gregg C Fonarow; Mohamad Navab; Alan M Fogelman
Journal:  Curr Atheroscler Rep       Date:  2007-01       Impact factor: 5.113

Review 4.  Oxidized low-density lipoprotein.

Authors:  Sampath Parthasarathy; Achuthan Raghavamenon; Mahdi Omar Garelnabi; Nalini Santanam
Journal:  Methods Mol Biol       Date:  2010

5.  Oxidation-induced loss of the ability of HDL to counteract the inhibitory effect of oxidized LDL on vasorelaxation.

Authors:  Laurence Perségol; Marie-Claude Brindisi; David Rageot; Jean-Paul Pais de Barros; Serge Monier; Bruno Vergès; Laurence Duvillard
Journal:  Heart Vessels       Date:  2014-07-17       Impact factor: 2.037

6.  Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization.

Authors:  Su Duy Nguyen; Dai-Eun Sok
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

Review 7.  Oxidative risk for atherothrombotic cardiovascular disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

8.  Oxidative Stress and Alterations of Paraoxonases in Atopic Dermatitis.

Authors:  Oriana Simonetti; Tiziana Bacchetti; Gianna Ferretti; Elisa Molinelli; Giulio Rizzetto; Luisa Bellachioma; Annamaria Offidani
Journal:  Antioxidants (Basel)       Date:  2021-04-28

9.  The relationships of leptin, adiponectin levels and paraoxonase activity with metabolic and cardiovascular risk factors in females treated with psychiatric drugs.

Authors:  Aliye Ozenoglu; Huriye Balci; Serdal Ugurlu; Erkan Caglar; Hafize Uzun; Cihat Sarkis; Can Gunay; Engin Eker E
Journal:  Clinics (Sao Paulo)       Date:  2008-10       Impact factor: 2.365

10.  In vivo administration of BL-3050: highly stable engineered PON1-HDL complexes.

Authors:  Leonid Gaidukov; Dganit Bar; Shiri Yacobson; Esmira Naftali; Olga Kaufman; Rinat Tabakman; Dan S Tawfik; Etgar Levy-Nissenbaum
Journal:  BMC Clin Pharmacol       Date:  2009-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.